Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Computational insights into the allosteric behavior of mini proinsulin driven by C peptide mobility

Open access
Ayan, Esra · 2025 · Scientific Reports

Published version of a preprint

Abstract

The production of recombinant insulin remains challenging, particularly in enhancing refolding efficiency and bioactivity. Mini-proinsulin analogs, which involve reducing the length of the C-peptide, offer potential improvements in insulin production. This study aims to evaluate mini-proinsulin analogs' design and receptor binding dynamics to optimize recombinant insulin production in E. coli. Mini-proinsulin analogs were engineered by replacing the 33-residue C-peptide with a pentapeptide sequence to improve refolding. The three-dimensional structure of mini-proinsulin was predicted using AlphaFold and performed docking analysis of mini-proinsulin analogs to the insulin receptor using AutoDock Tools, with comparisons made to previously available NMR-determined analog and the native insulin-insulin receptor complex. Normal Mode Analyses (GNM and ANM) were performed in detail to assess binding dynamics. In silico analyses revealed that mini-proinsulin analogs closely replicate the structural features of native insulin and display receptor binding dynamics similar to native insulin, though they follow distinct receptor interaction paths. All analysis suggests that C-peptide mobility may contribute to the allosteric behavior observed in mini-proinsulin analogs during receptor interaction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-025-92799-8

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Structural representation of mini-analogs for calculated and experimental co-complexes. (A) AlphaFold prediction of the novel designer mini-proinsulin (nMPI2). (B) Experimental structure of mini-proinsulin from the Protein Data Bank (PDB ID: 1EFE), referred to as MPI2. (C) Experimental structure of native insulin from the PDB (ID: 3I40). RMSD values between the structures are indicated with bidirectional arrows. (D) Docking co-complex of the experimental insulin receptor (IR, shown in green) and nMPI2, indicating a relatively higher affinity score. (E) Docking co-complex of the experimental IR (green) and MPI2, indicating a relatively lower affinity score. (F) Experimental IR-INS Cryo-EM co-complex from the PDB (ID: 6VEP). (G–I) Poisson-Boltzmann electrostatics of the docking and experimental co-complexes, illustrating the charge-smoothed protein contact potential. Red regions represent areas of negative electrostatic potential, blue regions indicate areas of positive electrostatic potential, and white (or neutral) regions represent areas with near-neutral electrostatic potential.
Fig. 1 Structural representation of mini-analogs for calculated and experimental co-complexes. (A) AlphaFold prediction of the novel designer mini-proinsulin (nMPI2). (B) Experimental structure of mini-proinsulin from the Protein Data Bank (PDB ID: 1EFE), referred to as MPI2. (C) Experimental structure of native insulin from the PDB (ID: 3I40). RMSD values between the structures are indicated with bidirectional arrows. (D) Docking co-complex of the experimental insulin receptor (IR, shown in green) and nMPI2, indicating a relatively higher affinity score. (E) Docking co-complex of the experimental IR (green) and MPI2, indicating a relatively lower affinity score. (F) Experimental IR-INS Cryo-EM co-complex from the PDB (ID: 6VEP). (G–I) Poisson-Boltzmann electrostatics of the docking and experimental co-complexes, illustrating the charge-smoothed protein contact potential. Red regions represent areas of negative electrostatic potential, blue regions indicate areas of positive electrostatic potential, and white (or neutral) regions represent areas with near-neutral electrostatic potential.CC BY-NC-ND · PubMed Central
Fig. 2 Structural overlays aligning the mini-proinsulin analogs with the insulin receptor to clarify probable binding mode differs. Panel A illustrates the native insulin-receptor (INS-IR) binding mode, obtained from the PDB structure (ID: 6VEP). Panel B shows a docking co-complex between the insulin receptor (extracted from the 6VEP structure) and mini-proinsulin (M2PI-IR) derived from the 1EFE PDB structure. This complex shows an alternate binding conformation, likely due to the presence of the C-peptide. Panel C presents another docking co-complex between the insulin receptor (6VEP) and a novel designer mini-proinsulin (nM2PI-IR) modeled using the AlphaFold tool, which demonstrates significant conformational changes in receptor binding. Panel D compares the superposition of INS-IR and M2PI-IR co-complexes, revealing slight differences in the binding of Chain A (ChA). Panel E shows a superposition of INS-IR and nM2PI-IR, highlighting substantial differences in both Chain A (ChA) and Chain B (ChB) conformations. Panel F compares the M2PI-IR and nM2PI-IR co-complexes, demonstrating pronounced differences in the ChA and ChB peptides. Panel G overlays INS-IR, M2PI-IR, and nM2PI-IR co-complexes, showing that both chains of nM2PI-IR exhibit significant distinctions compared to the other co-complexes. Panel H focuses on Chain A (IR binding site 1: G1A, I2A, V3A, E4A, Y19A, and N21A) of the M2PI analog, which exhibits lower binding affinity than native insulin. Panel I highlights that Chain B (IR binding site 1: GB8, SB9, LB11, VB12, YB16, FB24, FB25, YB26) of M2PI demonstrates strong binding affinity to the insulin receptor, comparable to native insulin’s Chain B. Panel J indicates that residues G1A, I2A, V3A, E4A, and Y19A of Chain A in nM2PI are localized on the left side of the co-complex relative to native insulin, resulting in a strong affinity for residues P716, R717, and P718 in the aCT domain of the insulin receptor. Panel K shows that, except for residue L11B, the other IR-binding residues of Chain B in nM2PI exhibit strong affinity to both the αCT and L1 domains of the insulin receptor, albeit with distinct binding patterns compared to native insulin. Panel L and N focuses on Chain A (IR binding site 2: T8A, I10A, S12A, E13A, and L17A) of the M2PI and nM2PI analogs, respectively, which those residues in both forms exhibit similar localization on IR compared to native insulin. Panel M and O highlights that Chain B (IR binding site 2: H10B, E13B, and L17B) of M2PI and nM2PI forms demonstrate those residues of both forms shows close proximity to αCT domain of IR.
Fig. 2 Structural overlays aligning the mini-proinsulin analogs with the insulin receptor to clarify probable binding mode differs. Panel A illustrates the native insulin-receptor (INS-IR) binding mode, obtained from the PDB structure (ID: 6VEP). Panel B shows a docking co-complex between the insulin receptor (extracted from the 6VEP structure) and mini-proinsulin (M2PI-IR) derived from the 1EFE PDB structure. This complex shows an alternate binding conformation, likely due to the presence of the C-peptide. Panel C presents another docking co-complex between the insulin receptor (6VEP) and a novel designer mini-proinsulin (nM2PI-IR) modeled using the AlphaFold tool, which demonstrates significant conformational changes in receptor binding. Panel D compares the superposition of INS-IR and M2PI-IR co-complexes, revealing slight differences in the binding of Chain A (ChA). Panel E shows a superposition of INS-IR and nM2PI-IR, highlighting substantial differences in both Chain A (ChA) and Chain B (ChB) conformations. Panel F compares the M2PI-IR and nM2PI-IR co-complexes, demonstrating pronounced differences in the ChA and ChB peptides. Panel G overlays INS-IR, M2PI-IR, and nM2PI-IR co-complexes, showing that both chains of nM2PI-IR exhibit significant distinctions compared to the other co-complexes. Panel H focuses on Chain A (IR binding site 1: G1A, I2A, V3A, E4A, Y19A, and N21A) of the M2PI analog, which exhibits lower binding affinity than native insulin. Panel I highlights that Chain B (IR binding site 1: GB8, SB9, LB11, VB12, YB16, FB24, FB25, YB26) of M2PI demonstrates strong binding affinity to the insulin receptor, comparable to native insulin’s Chain B. Panel J indicates that residues G1A, I2A, V3A, E4A, and Y19A of Chain A in nM2PI are localized on the left side of the co-complex relative to native insulin, resulting in a strong affinity for residues P716, R717, and P718 in the aCT domain of the insulin receptor. Panel K shows that, except for residue L11B, the other IR-binding residues of Chain B in nM2PI exhibit strong affinity to both the αCT and L1 domains of the insulin receptor, albeit with distinct binding patterns compared to native insulin. Panel L and N focuses on Chain A (IR binding site 2: T8A, I10A, S12A, E13A, and L17A) of the M2PI and nM2PI analogs, respectively, which those residues in both forms exhibit similar localization on IR compared to native insulin. Panel M and O highlights that Chain B (IR binding site 2: H10B, E13B, and L17B) of M2PI and nM2PI forms demonstrate those residues of both forms shows close proximity to αCT domain of IR.CC BY-NC-ND · PubMed Central
Fig. 3 Cross-correlation and calculated B-factor by GNM comparisons between calculated and experimental co-complexes. (A) Cross-correlation for IR-nM2PI. Highlight square indicated docking insulin monomer’ cross-correlation. Residue pairs exhibiting correlated motion, moving in the same direction, are depicted in red regions (Cijorient > 0), while those exhibiting anticorrelated motion, moving in opposite directions, are represented in blue regions (Cijorient < 0). Uncorrelated residue pairs are shown in green (Cijorient = 0.0), as indicated by the color bar on lower left corner. (B) Cross-correlation for nM2PI monomer within IR-nM2PI co-complex. (C) B-factor of nM2PI monomer within IR-nM2PI co-complex. (D) Cross-correlation for nM2PI monomer in isolation. (E) B-factor of nM2PI monomer in isolation. (F) Cross-correlation for IR-M2PI. (G) Cross-correlation for M2PI monomer within IR-M2PI co-complex. (H) B-factor of M2PI monomer within IR-M2PI co-complex. (I) Cross-correlation for M2PI monomer in isolation. (J) B-factor of M2PI monomer in isolation. (K) Cross-correlation for IR-INS. (L) Cross-correlation for INS monomer within IR-INS co-complex. (M) B-factor of INS monomer within IR-INS co-complex. (N) Cross-correlation for INS monomer in isolation. (O) B-factor of INS monomer in isolation.
Fig. 3 Cross-correlation and calculated B-factor by GNM comparisons between calculated and experimental co-complexes. (A) Cross-correlation for IR-nM2PI. Highlight square indicated docking insulin monomer’ cross-correlation. Residue pairs exhibiting correlated motion, moving in the same direction, are depicted in red regions (Cijorient > 0), while those exhibiting anticorrelated motion, moving in opposite directions, are represented in blue regions (Cijorient < 0). Uncorrelated residue pairs are shown in green (Cijorient = 0.0), as indicated by the color bar on lower left corner. (B) Cross-correlation for nM2PI monomer within IR-nM2PI co-complex. (C) B-factor of nM2PI monomer within IR-nM2PI co-complex. (D) Cross-correlation for nM2PI monomer in isolation. (E) B-factor of nM2PI monomer in isolation. (F) Cross-correlation for IR-M2PI. (G) Cross-correlation for M2PI monomer within IR-M2PI co-complex. (H) B-factor of M2PI monomer within IR-M2PI co-complex. (I) Cross-correlation for M2PI monomer in isolation. (J) B-factor of M2PI monomer in isolation. (K) Cross-correlation for IR-INS. (L) Cross-correlation for INS monomer within IR-INS co-complex. (M) B-factor of INS monomer within IR-INS co-complex. (N) Cross-correlation for INS monomer in isolation. (O) B-factor of INS monomer in isolation.CC BY-NC-ND · PubMed Central
Fig. 4 Comparison of individual 5 slow ANM mode direction of motions in INS, M2PI, and nM2PI bound to the IR. (A) Cross-correlations of IR-INS map by ANM. Residue pairs exhibiting correlated motion, moving in the same direction, are depicted in red regions (Cijorient > 0), while those exhibiting anticorrelated motion, moving in opposite directions, are represented in blue regions (Cijorient < 0) (B) Mode 5 of IR-INS is drawn on the structure. Ribbon representation was rendered blue to gray and red coloring, representing high to low mobility (C) Cross-correlations of IR-M2PI map by ANM. (D) Mode 5 of IR-M2PI is drawn on the structure. (E) Cross-correlations of IR-nM2PI map by ANM. (F) Mode 5 of IR-nM2PI is drawn on the structure.
Fig. 4 Comparison of individual 5 slow ANM mode direction of motions in INS, M2PI, and nM2PI bound to the IR. (A) Cross-correlations of IR-INS map by ANM. Residue pairs exhibiting correlated motion, moving in the same direction, are depicted in red regions (Cijorient > 0), while those exhibiting anticorrelated motion, moving in opposite directions, are represented in blue regions (Cijorient < 0) (B) Mode 5 of IR-INS is drawn on the structure. Ribbon representation was rendered blue to gray and red coloring, representing high to low mobility (C) Cross-correlations of IR-M2PI map by ANM. (D) Mode 5 of IR-M2PI is drawn on the structure. (E) Cross-correlations of IR-nM2PI map by ANM. (F) Mode 5 of IR-nM2PI is drawn on the structure.CC BY-NC-ND · PubMed Central
Fig. 5 Structural localization of potential receptor interaction residues and their GNM analysis. (A) Native αCT-INS interaction residues adapted from PDB structure under the 6VEP accession code. Also, cross-correlation analysis between αCT domain and INS to emphasize their strong collective motion. (B) αCT-M2PI interaction residues determined by 10 fastest GNM modes and cross-correlation analysis between αCT domain and M2PI to emphasize their relatively strong collective motion. (C) αCT-nM2PI interaction residues determined by 10 fastest GNM modes and cross-correlation analysis between αCT domain and nM2PI to emphasize their strong collective motion. (D) Turn panel C to 90 degrees for inspecting the detailed interaction between the αCT- nM2PI complex. Residue pairs exhibiting correlated motion, moving in the same direction, are depicted in red regions (Cijorient > 0), while those exhibiting anticorrelated motion, moving in opposite directions, are represented in blue regions (Cijorient < 0). Uncorrelated residue pairs are shown in green (Cijorient = 0.0), as indicated by the color bar in those panels. (E,F) Ten fastest GNM modes of αCT-mini analogs interactions. Potential hot loci have been labelled with relevant residues.
Fig. 5 Structural localization of potential receptor interaction residues and their GNM analysis. (A) Native αCT-INS interaction residues adapted from PDB structure under the 6VEP accession code. Also, cross-correlation analysis between αCT domain and INS to emphasize their strong collective motion. (B) αCT-M2PI interaction residues determined by 10 fastest GNM modes and cross-correlation analysis between αCT domain and M2PI to emphasize their relatively strong collective motion. (C) αCT-nM2PI interaction residues determined by 10 fastest GNM modes and cross-correlation analysis between αCT domain and nM2PI to emphasize their strong collective motion. (D) Turn panel C to 90 degrees for inspecting the detailed interaction between the αCT- nM2PI complex. Residue pairs exhibiting correlated motion, moving in the same direction, are depicted in red regions (Cijorient > 0), while those exhibiting anticorrelated motion, moving in opposite directions, are represented in blue regions (Cijorient < 0). Uncorrelated residue pairs are shown in green (Cijorient = 0.0), as indicated by the color bar in those panels. (E,F) Ten fastest GNM modes of αCT-mini analogs interactions. Potential hot loci have been labelled with relevant residues.CC BY-NC-ND · PubMed Central
Fig. 6 Pictorial representation the allosteric behavior of M2PI and nM2PI compared INS in receptor binding driven by C-peptide mobility. (A) Comparison of how the M2PI position alters its conformation after binding to the αCT receptor domain compared to the INS position within the IR. Cross-correlation analysis by GNM between aCT and C-peptide within the IR-M2PI co-complex. N-terminal of aCT shows at least 50% correlation with C-peptide of IR-M2PI co-complex. (B) Comparison of how the nM2PI position alters its conformation after binding to the αCT receptor domain compared to the INS position within the IR. Cross-correlation analysis by GNM between aCT and C-peptide within the IR-nM2PI co-complex. aCT shows strong correlation with C-peptide of IR-nM2PI co-complex. Residue pairs exhibiting correlated motion, moving in the same direction, are depicted in red regions (Cijorient > 0), while those exhibiting anticorrelated motion, moving in opposite directions, are represented in blue regions (Cijorient < 0). Uncorrelated residue pairs are shown in green (Cijorient = 0.0), as indicated by the color bar in right panels.
Fig. 6 Pictorial representation the allosteric behavior of M2PI and nM2PI compared INS in receptor binding driven by C-peptide mobility. (A) Comparison of how the M2PI position alters its conformation after binding to the αCT receptor domain compared to the INS position within the IR. Cross-correlation analysis by GNM between aCT and C-peptide within the IR-M2PI co-complex. N-terminal of aCT shows at least 50% correlation with C-peptide of IR-M2PI co-complex. (B) Comparison of how the nM2PI position alters its conformation after binding to the αCT receptor domain compared to the INS position within the IR. Cross-correlation analysis by GNM between aCT and C-peptide within the IR-nM2PI co-complex. aCT shows strong correlation with C-peptide of IR-nM2PI co-complex. Residue pairs exhibiting correlated motion, moving in the same direction, are depicted in red regions (Cijorient > 0), while those exhibiting anticorrelated motion, moving in opposite directions, are represented in blue regions (Cijorient < 0). Uncorrelated residue pairs are shown in green (Cijorient = 0.0), as indicated by the color bar in right panels.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Metadata

Authors
Ayan, E.
Affiliations
Istanbul Medipol University (TR)
Corresponding author
Ayan, Esra
Venue
Scientific Reports
Published
2025-03-08
Volume
15
Issue
1
Pages
8065-8065
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4408217924
Cited by
3
References
26
Citations by year
2026: 2 · 2025: 1
FWCI
0.90
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords
C-peptide, insulin receptor binding, recombinant insulin production, protein refolding, normal mode analysis
MeSH terms
Allosteric Regulation, C-Peptide, Escherichia coli, Humans, Insulin, Proinsulin, Protein Binding, Receptor, Insulin, Recombinant Proteins, Molecular Dynamics Simulation, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Computational insights into the allosteric behavior of mini proinsulin driven by C peptide mobility. https://app.cochat.ai/papers/10.1038/s41598-025-92799-8
The paper
Ayan, E. (2025). Computational insights into the allosteric behavior of mini proinsulin driven by C peptide mobility. Scientific Reports. https://doi.org/10.1038/s41598-025-92799-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.